Skip to NavigationSkip to content

News

0
Roche's Kadcyla beats Herceptin breast cancer disease recurrence and death risk
Roche has unveiled new data for its antibody-drug conjugate Kadcyla (trastuzumab emtansine) in the treatment of patients with HER2-positive early...
0
Novartis and Bayer seek to oppose High Court ruling over NHS decision to use cheaper drug
Swiss multinational Novartis have joined German pharma firm Bayer in appealing a High Court ruling over 12 NHS clinical commissioning groups (CCGs...
0
Trump administration propose ruling requiring price transparency on TV ads
US Health and Human Services Secretary Alex Azar, has announced a proposal which would require pharma firms to include the list price of any drug...
0
Amgen launches first biosimilar of best-selling Humira in Europe
Amgen has announced the launch of a proprietary biosimilar version of its best-selling drug Humira (adalimumab) across all European markets,...
>> More News Stories

Features

AI, big data: Making a case for faster drug discovery

They’re two of the biggest buzzwords getting professionals excited across pharma – Anjali Shukla explores the ways in which AI and big data are...

>> More Features
>> More News Stories